Synopsis
Synopsis
0
VMF
0
Australia
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 397.4 g/mol |
---|---|
Molecular Formula | C18H24NO7P |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 1 |
Exact Mass | 397.12903910 g/mol |
Monoisotopic Mass | 397.12903910 g/mol |
Topological Polar Surface Area | 120 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 558 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 5 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Certificate Number : CEP 1997-118 - Rev 12
Issue Date : 2024-03-01
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Nosa Chemical Co., Ltd.
Registration Date : 2020-06-16
Registration Number : 20200616-209-J-616
Manufacturer Name : Saneca Pharmaceuticals as
Manufacturer Address : Nitrianska 100, 920 27 Hlohovec, Slovak Republic
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Date of Issue : 2019-01-02
Valid Till : 2021-01-02
Written Confirmation Number : 665/93733
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20787
Submission : 2007-08-23
Status : Active
Type : II
Certificate Number : R1-CEP 2016-295 - Rev 00
Issue Date : 2022-10-06
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Samung Industrial Co., Ltd.
Registration Date : 2021-03-16
Registration Number : 20210316-209-J-603
Manufacturer Name : Macfarlan Smith Limited@Macfarlan Smith Limited@Tasmanian Alkaloids Pty Limited
Manufacturer Address : Three Trees Road Newbie, Annan DG12 5QH United Kingdom@10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom@160 Birralee Road, Westbury, Tasmania, 7303, Australia
Certificate Number : CEP 2021-385 - Rev 01
Issue Date : 2024-02-06
Type : Chemical
Substance Number : 74
Status : Valid
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-16
Pay. Date : 2012-11-23
DMF Number : 25856
Submission : 2012-03-30
Status : Active
Type : II
NDC Package Code : 51634-0999
Start Marketing Date : 1986-06-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : R1-CEP 1999-053 - Rev 03
Issue Date : 2014-12-19
Type : Chemical
Substance Number : 74
Status : Valid
Registrant Name : Baeksu Pharmaceutical Co., Ltd.
Registration Date : 2021-03-16
Registration Number : 20210316-209-J-603(1)
Manufacturer Name : Macfarlan Smith Limited@Macfarlan Smith Limited@Tasmanian Alkaloids Pty Limited
Manufacturer Address : Three Trees Road, Newbie, Annan Dumfriesshire, DG12 5QH, United Kingdom@10 Wheatfield Road, Edinburgh, EH11 2QA, United Kingdom@160 Birralee Road, Westbury, Tasmania, 7303, Australia
Certificate Number : R1-CEP 2010-052 - Rev 01
Issue Date : 2019-01-18
Type : Chemical
Substance Number : 74
Status : Valid
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-05
Pay. Date : 2012-12-27
DMF Number : 20213
Submission : 2007-01-29
Status : Active
Type : II
NDC Package Code : 0792-0644
Start Marketing Date : 2007-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Certificate Number : CEP 1997-118 - Rev 12
Status : Valid
Issue Date : 2024-03-01
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 2016-295 - Rev 00
Status : Valid
Issue Date : 2022-10-06
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 1999-053 - Rev 03
Status : Valid
Issue Date : 2014-12-19
Type : Chemical
Substance Number : 74
Codeine Phosphate Hemihydrate, Process II
Certificate Number : CEP 2021-385 - Rev 01
Status : Valid
Issue Date : 2024-02-06
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 2010-052 - Rev 01
Status : Valid
Issue Date : 2019-01-18
Type : Chemical
Substance Number : 74
Certificate Number : R0-CEP 2017-232 - Rev 00
Status : Expired
Issue Date : 2019-03-13
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 1995-024 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2006-08-22
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 1999-152 - Rev 04
Status : Valid
Issue Date : 2018-10-04
Type : Chemical
Substance Number : 74
Certificate Number : R1-CEP 2007-064 - Rev 00
Status : Valid
Issue Date : 2013-10-04
Type : Chemical
Substance Number : 74
Certificate Number : R0-CEP 2005-297 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2011-01-07
Type : Chemical
Substance Number : 74
Date of Issue : 2019-01-02
Valid Till : 2021-01-02
Written Confirmation Number : 665/93733
Address of the Firm : 28th km of Karaj Makhsous Road, Tehran, Iran
About the Company : EUROAPI is focused on reinventing active ingredient solutions to meet the needs of customers and patients worldwide sustainably. We are a leading player in APIs with approximately ...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
About the Company : Founded in 1979, Noramco specializes in the development and manufacturing of APIs for both opioid and non-opioid products. With expertise in controlled substance development and ma...
About the Company : Alcaliber is a benchmark in the World Drug Industry both in terms of quality and innovation, integrity and commitment to our customers. We are a leading company: in 2014 we were th...
About the Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acquisition of the mult...
About the Company : Danesh Kimia Pharmed Co. was established on 2011 by industrial and university researchers in order to invest on the production of new pharmaceutical molecules and their ready to us...
About the Company : Established in 1995, Kimyagaran Emrooz Chemical Industries Co. is recognized as one of the major leading production enterprises in the ethoxylation and propoxylation industry for m...
About the Company : Mallinckrodt Pharmaceuticals is a multibillion dollar specialty biopharmaceutical company focused on our mission: Managing Complexity. Improving Lives. We provide medicines to addr...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
Regulatory Info :
Registration Country : Iran
Acetaminophen; Codeine Phosphate
Brand Name :
Dosage Form : Tablet
Dosage Strength : 300MG; 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Guaifenesin; Pseudoephedrine Hydrochloride; Codeine Phosphate
Brand Name : Expectorant Codeine
Dosage Form : Syrup
Dosage Strength : 100MG; 30MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : Iran
Guaifenesin; Codeine Phosphate
Brand Name : Guaicodin
Dosage Form : Syrup
Dosage Strength : 100MG; 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Canada
Brand Name : MERSYNDOL WITH CODEINE
Dosage Form : TABLET
Dosage Strength : 8MG
Packaging : 24/100
Approval Date :
Application Number : 2047667
Regulatory Info :
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : FIORINAL W/CODEINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 1990-10-26
Application Number : 19429
Regulatory Info : DISCN
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 2001-11-30
Application Number : 75231
Regulatory Info : RX
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 325MG;50MG;40MG;30MG
Packaging :
Approval Date : 2004-06-10
Application Number : 76560
Regulatory Info : RX
Registration Country : USA
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Regulatory Info : RX
Registration Country : USA
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Brand Name : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 300MG;50MG;40MG;30MG
Packaging :
Approval Date : 2012-07-19
Application Number : 76560
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Coughcod Senior
Dosage Form : SYR
Dosage Strength : 10mg/5ml
Packaging : 100X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Lenadol
Dosage Form : TAB
Dosage Strength : 10mg
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Codeine Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Codeine Phosphate manufacturer or Codeine Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Codeine Phosphate manufacturer or Codeine Phosphate supplier.
PharmaCompass also assists you with knowing the Codeine Phosphate API Price utilized in the formulation of products. Codeine Phosphate API Price is not always fixed or binding as the Codeine Phosphate Price is obtained through a variety of data sources. The Codeine Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PROMETHAZINE VC W/ CODEINE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PROMETHAZINE VC W/ CODEINE, including repackagers and relabelers. The FDA regulates PROMETHAZINE VC W/ CODEINE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PROMETHAZINE VC W/ CODEINE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of PROMETHAZINE VC W/ CODEINE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A PROMETHAZINE VC W/ CODEINE supplier is an individual or a company that provides PROMETHAZINE VC W/ CODEINE active pharmaceutical ingredient (API) or PROMETHAZINE VC W/ CODEINE finished formulations upon request. The PROMETHAZINE VC W/ CODEINE suppliers may include PROMETHAZINE VC W/ CODEINE API manufacturers, exporters, distributors and traders.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A PROMETHAZINE VC W/ CODEINE DMF (Drug Master File) is a document detailing the whole manufacturing process of PROMETHAZINE VC W/ CODEINE active pharmaceutical ingredient (API) in detail. Different forms of PROMETHAZINE VC W/ CODEINE DMFs exist exist since differing nations have different regulations, such as PROMETHAZINE VC W/ CODEINE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A PROMETHAZINE VC W/ CODEINE DMF submitted to regulatory agencies in the US is known as a USDMF. PROMETHAZINE VC W/ CODEINE USDMF includes data on PROMETHAZINE VC W/ CODEINE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The PROMETHAZINE VC W/ CODEINE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The PROMETHAZINE VC W/ CODEINE Drug Master File in Japan (PROMETHAZINE VC W/ CODEINE JDMF) empowers PROMETHAZINE VC W/ CODEINE API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the PROMETHAZINE VC W/ CODEINE JDMF during the approval evaluation for pharmaceutical products. At the time of PROMETHAZINE VC W/ CODEINE JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a PROMETHAZINE VC W/ CODEINE Drug Master File in Korea (PROMETHAZINE VC W/ CODEINE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of PROMETHAZINE VC W/ CODEINE. The MFDS reviews the PROMETHAZINE VC W/ CODEINE KDMF as part of the drug registration process and uses the information provided in the PROMETHAZINE VC W/ CODEINE KDMF to evaluate the safety and efficacy of the drug.
After submitting a PROMETHAZINE VC W/ CODEINE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their PROMETHAZINE VC W/ CODEINE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with KDMF on PharmaCompass.
A PROMETHAZINE VC W/ CODEINE CEP of the European Pharmacopoeia monograph is often referred to as a PROMETHAZINE VC W/ CODEINE Certificate of Suitability (COS). The purpose of a PROMETHAZINE VC W/ CODEINE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of PROMETHAZINE VC W/ CODEINE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of PROMETHAZINE VC W/ CODEINE to their clients by showing that a PROMETHAZINE VC W/ CODEINE CEP has been issued for it. The manufacturer submits a PROMETHAZINE VC W/ CODEINE CEP (COS) as part of the market authorization procedure, and it takes on the role of a PROMETHAZINE VC W/ CODEINE CEP holder for the record. Additionally, the data presented in the PROMETHAZINE VC W/ CODEINE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the PROMETHAZINE VC W/ CODEINE DMF.
A PROMETHAZINE VC W/ CODEINE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. PROMETHAZINE VC W/ CODEINE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with CEP (COS) on PharmaCompass.
A PROMETHAZINE VC W/ CODEINE written confirmation (PROMETHAZINE VC W/ CODEINE WC) is an official document issued by a regulatory agency to a PROMETHAZINE VC W/ CODEINE manufacturer, verifying that the manufacturing facility of a PROMETHAZINE VC W/ CODEINE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting PROMETHAZINE VC W/ CODEINE APIs or PROMETHAZINE VC W/ CODEINE finished pharmaceutical products to another nation, regulatory agencies frequently require a PROMETHAZINE VC W/ CODEINE WC (written confirmation) as part of the regulatory process.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing PROMETHAZINE VC W/ CODEINE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for PROMETHAZINE VC W/ CODEINE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture PROMETHAZINE VC W/ CODEINE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain PROMETHAZINE VC W/ CODEINE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a PROMETHAZINE VC W/ CODEINE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of PROMETHAZINE VC W/ CODEINE suppliers with NDC on PharmaCompass.
PROMETHAZINE VC W/ CODEINE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PROMETHAZINE VC W/ CODEINE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PROMETHAZINE VC W/ CODEINE GMP manufacturer or PROMETHAZINE VC W/ CODEINE GMP API supplier for your needs.
A PROMETHAZINE VC W/ CODEINE CoA (Certificate of Analysis) is a formal document that attests to PROMETHAZINE VC W/ CODEINE's compliance with PROMETHAZINE VC W/ CODEINE specifications and serves as a tool for batch-level quality control.
PROMETHAZINE VC W/ CODEINE CoA mostly includes findings from lab analyses of a specific batch. For each PROMETHAZINE VC W/ CODEINE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PROMETHAZINE VC W/ CODEINE may be tested according to a variety of international standards, such as European Pharmacopoeia (PROMETHAZINE VC W/ CODEINE EP), PROMETHAZINE VC W/ CODEINE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PROMETHAZINE VC W/ CODEINE USP).